H1-histamine receptor affinity predicts weight gain with antidepressants

European Neuropsychopharmacology

Volumn 26, Issue 10, 2016, Pages 1673-1677

  Salvi, Virginio ^a   Mencacci, Claudio ^a   Barone Adesi, Francesco ^b  

^a ASST FATEBENEFRATELLI SACCO UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Antidepressants; Histamine; Receptor affinity; Weight gain

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; HISTAMINE H1 RECEPTOR; MUSCARINIC M3 RECEPTOR; SEROTONIN 2C RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR;

ARTICLE; BODY WEIGHT DISORDER; DRUG RECEPTOR BINDING; HUMAN; INHIBITION CONSTANT; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RECEPTOR AFFINITY; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; BODY WEIGHT GAIN; DRUG EFFECTS; FACTUAL DATABASE; METABOLISM;

ANTIDEPRESSIVE AGENTS; DATABASES, FACTUAL; HUMANS; META-ANALYSIS AS TOPIC; RECEPTOR, MUSCARINIC M3; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, HISTAMINE H1; WEIGHT GAIN;

EID: 84991089501     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2016.08.012     Document Type: Article

References (21)

1. Arterburn, D., Sofer, T., Boudreau, D.M., Bogart, A., Westbrook, E.O., Theis, M.K., Simon, G., Haneuse, S., Long-term weight change after initiating second-generation antidepressants. J. Clin. Med., 5(4), 2016 pii: E48.
2. Correll, C.U., Detraux, J., De Lepeleire, J., De Hert, M., Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 14:2 (2015), 119–136.
3. De Hert, M., Dekker, J.M., Wood, D., Kahl, K.G., Holt, R.I., Möller, H.J., Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur. Psychiatry, 24, 2009, 412–424.
4. Derijks, H.J., Heerdink, E.R., Janknegt, R., De Koning, F.H., Olivier, B., Loonen, A.J.M., Egberts, A.C., Visualizing pharmacological activities of antidepressants: a novel approach. Open Pharmacol. J. 2 (2008), 54–62.
5. Derijks, H.J., Meyboom, R.H.B., Heerdink, E.R., De Koning, F.H., Janknegt, R., Lindquist, M., Egberts, A.C., The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur. J. Clin. Pharmacol. 64 (2008), 531–538.
6. Grundy, A., Cotterchio, M., Kirsh, V.A., Kreiger, N., Associations between anxiety, depression, antidepressant medication, obesity and weight gain among Canadian women. PLoS One, 9(6), 2014, e99780.
7. Hasnain, M., Vieweg, W.V., Hollett, B., Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians. Postgrad. Med. 124:4 (2012), 154–167.
8. He, M., Zhang, Q., Deng, C., Wang, H., Lian, J., Huang, X.F., Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats. Psychoneuroendocrinol 42 (2014), 153–164.
9. Lam, D.D., Garfield, A.S., Marston, O.J., Shaw, J., Heisler, L.K., Brain serotonin system in the coordination of food intake and body weight. Pharmacol. Biochem. Behav. 97:1 (2010), 84–91.
10. Kroeze, W.K., Hufeisen, S.J., Popadak, B.A., Renock, S.M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H.Y., Roth, B.L., H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28:3 (2003), 519–526.
11. Lee, S.H., Paz-Filho, G., Mastronardi, C., Licinio, J., Wong, M.L., Is increased antidepressant exposure a contributory factor to the obesity pandemic. Transl. Psychiatry, 6, 2016, e759.
12. Lian, J., Huang, X.F., Pai, N., Deng, C., Ameliorating antipsychotic-induced weight gain by betahistine: mechanisms and clinical implications. Pharmacol. Res. 106 (2016), 51–63.
13. Maina, G., Albert, U., Salvi, V., Bogetto, F., Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors. J. Clin. Psychiatry 65:10 (2004), 1365–1371.
14. Matsui-Sakata, A., Ohtani, H., Sawada, Y., Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus. Drug Metab. Pharmacokinet. 20:5 (2005), 368–378.
15. McElroy, S.L., Obesity in patients with severe mental illness: overview and management. J. Clin. Psychiatry 70:Suppl 3 (), 12–21.
16. PDSP-database. 〈http://pdsp.med.unc.edu/kidb.php〉. Ki determinations were generously provided by the National Institute of Mental Health׳s Psychoactive Drug Screening Program, Contract # HHSN-271-2013-00017-C (NIMH PDSP).
17. Roerig, J.L., Steffen, K.J., Mitchell, J.E., Atypical antipsychotic-induced weight gain: insights into mechanisms of action. CNS Drugs 25:12 (2011), 1035–1059.
18. Salvi, V., Barone-Adesi, F., D׳Ambrosio, V., Albert, U., Maina, G., High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder. Psychopharmacol. (Berl.) 233:1 (2016), 49–56.
19. Schilling, C., Gilles, M., Blum, W.F., Daseking, E., Colla, M., Weber-Hamann, B., Lederbogen, F., Krumm, B., Heuser, I., Wudy, S.A., Kopf, D., Deuschle, M., Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?. J. Clin. Psychopharmacol. 33 (2013), 99–103.
20. Serretti, A., Mandelli, L., Antidepressants and body weight: a comprehensive review and meta-analysis. J. Clin. Psychiatry 71:10 (2010), 1259–1272.
21. Thompson, S.G., Higgins, J.P., How should meta-regression analyses be undertaken and interpreted?. Stat. Med. 21:11 (2002), 1559–1573.